Documentos relacionados

1. Molecular Capture of <i>Mycobacterium tuberculosis</i> Genomes Directly from Clinical Samples: A Potential Backup Approach for Epidemiological and Drug Susceptibility Inferences.
2. Connecting the dots: understanding how human mobility shapes TB epidemics.
3. The predicted impact of tuberculosis preventive therapy: the importance of disease progression assumptions.
4. Tools to Alleviate the Drug Resistance in <i>Mycobacterium tuberculosis</i>.
5. Insight into pathogenomics and phylogeography of hypervirulent and highly-lethal Mycobacterium tuberculosis strain cluster.
6. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
7. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
8. A One Health approach revealed the long-term role of <i>Mycobacterium caprae</i> as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022.
9. Completeness of tuberculosis case notifications in Germany in 2013-2017: first results of an inventory study.
10. Molecular characteristics of Mycobacterium tuberculosis drug-resistant isolates from HIV- and HIV+ tuberculosis patients in Russia.